Reponte, Demie N.
HRN: 21-65-48 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2022
CEFUROXIME 1.5GM (VIAL)
07/29/2022
08/05/2022
IV
1.5gm
Q8
Punctured Wound
Waiting Final Action